Boehringer Ingelheim Fremont, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 6701 Kaiser Drive, Fremont, California (CA) 94555, United States (USA)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3005925062 · DUNS 967820619
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-11-04
- VAIDrug Quality Assurance2018-08-24
- NAIDrug Quality Assurance2014-05-28
- VAIDrug Quality Assurance2012-08-07
- VAIDrug Quality Assurance2010-02-25
Drugs this plant is listed as making
2 distinct drugs across 16 products name this site in their FDA label.
- Adalimumab-adbmQuallent Pharmaceuticals Health Llc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.